Metabolic
Tesamorelin
A stabilised analogue of growth-hormone-releasing hormone (GHRH). Supplied as a reference peptide for research into GHRH-receptor signalling and the somatotropic axis.
£50
per vial · 10mg
Strength
Quantity
For research purposes only, where permitted by local regulations. Not for human or animal consumption. Not a medicine, and not intended to diagnose, treat, cure or prevent any disease.
About Tesamorelin
A stabilised analogue of growth-hormone-releasing hormone (GHRH). Supplied as a reference peptide for research into GHRH-receptor signalling and the somatotropic axis.
Areas of research interest
- GHRH-receptor signalling research
- Somatotropic axis reference work
- Peptide stability and identity assays
Research context
Tesamorelin is the one compound in this range with a dose a regulator has approved, under the name EGRIFTA, for a specific clinical indication. It is supplied here strictly as a research reference material.
Documentation
The manufacturer’s certificate of analysis for a recent production batch of Tesamorelin (10mg vial, lot TM10-20260313) is published here: certificate of analysis (PDF). It is issued by the manufacturer against their internal specification and includes the chromatogram for that lot.
The lot you receive may differ. Where we hold batch documentation for the lot supplied, it is available on request — quote your order reference on the contact page. We never substitute a document from a different batch as if it were yours.
Specifications
- Compound
- Tesamorelin
- CAS
- 218949-48-5
- Vial strengths
- 10mg
- Appearance
- Lyophilised powder
- Storage
- Store sealed, cool and dry, away from light
- Handling
- Laboratory handling and disposal procedures apply
- Intended use
- Research use only
Shipped tracked from the UK within 24 hours, in discreet, tamper-evident packaging. Free UK delivery over £100.
Same category
